D
Devyser Diagnostics AB
STO:DVYSR
Devyser Diagnostics AB
STO:DVYSR
Price:
101.8
SEK
-4.86%
Market Closed
Market Cap:
kr1.7B
Relative Value
The Relative Value of one DVYSR stock under the Base Case scenario is hidden SEK. Compared to the current market price of 101.8 SEK, Devyser Diagnostics AB is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DVYSR Relative Value
HIDDEN
Multiples Across Competitors
DVYSR Competitors Multiples
Devyser Diagnostics AB Competitors
Devyser Diagnostics AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
D
|
Devyser Diagnostics AB
STO:DVYSR
|
1.7B SEK | 7 | -67 | 106.5 | -127.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.4B USD | 6.7 | 171.4 | 16.6 | 23.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
199.5B USD | 5.4 | 25.8 | 14.8 | 14.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
189.8B USD | 6.5 | 23.3 | 15.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.5B USD | 10.1 | 32.3 | 23.7 | 24.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD | 5.8 | 18.5 | 14 | 16 | |
| AU |
|
CSL Ltd
ASX:CSL
|
74.1B AUD | 3.3 | 17.1 | 11.7 | 14.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.2B EUR | 14.3 | 33.5 | 57.2 | 58.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
